Set of techniques to measure and visualize aspects of the nervous system
POPULARITY
How do you turn massive clinical imaging data into insights that change lives? What does it take to move from a psychology undergrad to a pioneering role in pediatric brain research? And how can coding, connectomics, and curiosity shape a meaningful clinical career in neuroscience? In this inspiring episode of Neurocareers: Doing the Impossible!, we sit down with Dr. Puck Reeders, Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital. From her early days in Curacao to building novel neuroimaging pipelines in one of the nation's oldest pediatric epilepsy programs, Dr. Reeders shares her unique career path—and how she helps decode complex brain networks to improve surgical outcomes for children with intractable epilepsy. We explore: How connectomics and diffusion imaging guide surgical planning Her innovative research on white matter networks and neuromodulation responses The steep but rewarding path from zero coding skills to advanced tractography Tips for transitioning from psychology to clinical neuroscience Career advice for anyone eager to enter research-focused medical settings Whether you're a student exploring future careers, a neuroscientist curious about clinical impact, or just fascinated by how science meets medicine—you'll walk away informed and inspired. Chapters: 00:00:00 - Insights from a Neuroscience Research Scientist 00:03:00 - Functional Mapping Techniques for Epilepsy 00:08:43 - Transitioning from Medical School to Psychology 00:13:10 - Research Gaps in Epilepsy 00:17:10 - Understanding Connectomics in Epilepsy Treatment 00:21:53 - Combining Imaging Techniques in Research 00:24:50 - Coding Challenges in Research 00:27:12 - Coding Journey in Neuroscience 00:28:51 - Learning to Code: A Personal Journey 00:32:39 - The Importance of Networking 00:34:30 - Art's Role in Science Communication 00:37:38 - Landing a Job Through Networking 00:41:22 - Research Opportunities in Connectomics 00:46:49 - Exploring Diverse Career Opportunities 00:51:38 - Job Search Tips and Strategies 00:54:39 - Tips for Job Applications and Interviews 00:59:46 - From Medicine to Neuroscience Research 01:02:06 - Clinical Research and Pediatric Epilepsy About the Podcast Guest: Dr. Puck Reeders is a Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital in Miami, Florida https://www.nicklauschildrens.org/home Her work focuses on investigating aberrant brain networks in children with intractable epilepsy, applying advanced neuroimaging techniques to improve clinical outcomes in pediatric neurology. Originally from the Netherlands and raised on the island of Curaçao, Dr. Reeders brings a global perspective to her research. She holds a Bachelor of Science in Psychology and Chemistry from the University of Miami, and a PhD in Cognitive Neuroscience from Florida International University, where she also completed her postdoctoral training in the Allen Neurocircuitry and Cognition Lab. Dr. Reeders has over nine years of experience working with functional MRI (fMRI) and diffusion-weighted imaging (DWI) in both adults and children. Her current research explores the structural connectomics of pediatric epilepsy, the development of clinical imaging pipelines to detect white matter abnormalities, cortical dysplasias, and automated SPECT subtractions—bringing together cutting-edge science with translational clinical impact. Her expertise spans: Neuroimaging and clinical pipeline development Data analysis and scientific coding Translational neuroscience and surgical planning support Research project design and academic mentoring Outside of the lab, Dr. Reeders shares insights into neuroscience careers and research life on her educational Instagram: @Drpucky You can also connect with her professionally on LinkedIn: https://www.linkedin.com/in/puckreeders/ About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news
It's time to rewire for wellness—your brain holds the blueprint for healing, and Dr. Steven Resnick is here to show you how! In this powerful episode of The Manifested Podcast, Kathleen Cameron sits down with neurologist Dr. Steven Resnick to explore how subconscious beliefs and identity shape our physical health. Discover how neurology and manifestation intersect—and how rewiring your mind could be the key to lasting wellness. Don't miss Dr. Resnick's holistic take on healing that goes far beyond traditional medicine. In this episode: Your brain loves habits — even the unhealthy ones. Change takes awareness. Shifting your mindset can lead to real health breakthroughs. Positive self-talk and mindfulness help rewire old patterns. Beliefs and words can impact healing — even in medicine. Dr. Resnick shares how being present boosts well-being. About The Guest: Dr. Steven Resnick is the Medical Director of the Mount Sinai Comprehensive Stroke Center. Board-certified in Neurology and Vascular Neurology, Dr. Resnick is an attending Neurologist with direct supervision of internal medicine and medical students at Mount Sinai Hospital. Dr. Resnick has co-authored a textbook entitled Practical Neuroimaging in Stroke and has published articles in the Journal of the Peripheral Nervous System, the Journal of Neurology, and the Journal of Neurology, Neurosurgery, and Psychiatry. He has lectured extensively on stroke prevention, acute ischemic stroke, practical Neuroimaging in cerebrovascular disease, and other related topics. Clinical research includes studies of drug therapies to treat Neuromuscular diseases. Connect with Dr. Resnick Website: https://drstevenresnick.com/ Instagram: https://www.instagram.com/dr.stevenresnick Facebook: https://www.facebook.com/DrStevenResnick/ Podcast: https://drstevenresnick.com/the-healthy-mind-podcast/ Shop Iylia Premium Non-Alcoholics: https://iylia.com/ Subscribe To The Manifested Podcast With Kathleen Cameron: Apple Podcast | YouTube | Spotify Connect With The Kathleen Cameron: Facebook | Instagram | LinkedIn | Youtube | TikTok | Kathleencameronofficial.com Unlock Your Dreams with House of ManifestationA community where you take control of your destiny, manifest your desires, and create a life filled with abundance and purpose? Look no further than the House of Manifestation, where your transformation begins: https://houseofmanifestation.com/ About Kathleen Cameron: Kathleen Cameron, Chief Wealth Creator, 8-figure entrepreneur, and record-breaking author. In just 2 years, she built a 10 Million dollar business and continues to share her knowledge and expertise with all of whom she connects with. With her determination, unwavering faith, and powers of manifestation, she has helped over 100,000 people attract more love, money, and success into their lives. Her innovative approaches to Manifestation and utilizing the Laws of Attraction have led to the creation of one of the top global success networks, Diamond Academy Coaching, thousands of students have been able to experience quantum growth. The force behind her magnetic field has catapulted many students into a life beyond their wildest dreams and she is just getting started. Kathleen helps others step into their true potential and become the best version of themselves with their goals met. Kathleen graduated with two undergraduate degrees from the University of Windsor and the University of Toronto with a master's degree in nursing leadership. Her book, “Becoming The One", published by Hasmark Publishing, launched in August 2021 became an International Best Seller in five countries on the first day. This Podcast Is Produced, Engineered & Edited By: Simplified Impact
In this episode, we explore the intersection of AI, machine learning, and healthcare through the lens of neuroimaging and epilepsy diagnosis. Dr. Gavin Winston shares insights from his work using MRI data and machine learning to uncover subtle abnormalities in brain function. We discuss the cultural and ethical barriers to AI adoption in medicine, how predictive data analysis could transform the diagnostic workflow, and what the future holds for medical imaging in a world increasingly shaped by intelligent systems.Featuring:Gavin Winston – LinkedIn, WebsiteChris Benson – Website, GitHub, LinkedIn, XDaniel Whitenack – Website, GitHub, XLinks:Detection of Epileptogenic Focal Cortical Dysplasia Using Graph Neural Networks: A MELD StudyMachine Learning in Neuroimaging across DisciplinesAutomated and Interpretable Detection of Hippocampal Sclerosis in Temporal Lobe Epilepsy: AID-HSLiterature review and protocol for a prospective multicentre cohort study on multimodal prediction of seizure recurrence after unprovoked first seizureDeep learning in neuroimaging of epilepsyNon-parametric combination of multimodal MRI for lesion detection in focal epilepsyDetection of covert lesions in focal epilepsy using computational analysis of multimodal magnetic resonance imaging data
Have you ever noticed that your sense of time feels strangely elastic—sometimes minutes drag on endlessly, and other times hours vanish in a blink? If you have ADHD, this experience likely resonates deeply. This phenomenon, often called "time blindness," significantly impacts everyday life, from managing tasks and deadlines to social interactions and self-care routines.But why exactly is this such a persistent challenge for people with ADHD? Let's delve into the neuroscience behind time perception, understand why this struggle is more pronounced for ADHDers, and explore evidence-backed strategies and tools to help navigate daily life more effectively.⏰Understanding Time Blindness In ADHD brains, several neural networks responsible for tracking and managing time are impacted, including the prefrontal cortex, basal ganglia, and cerebellum. These areas are essential for precise time estimation, maintaining attention, and executing planned actions. Neuroimaging studies have shown reduced activity in these regions among individuals with ADHD, leading to significant impairments in accurately perceiving and managing time.Dopamine dysregulation also profoundly impacts time perception. Dopamine is critical for sustaining attention, regulating motivation, and anticipating rewards. In ADHD, irregular dopamine signaling leads the brain to rely excessively on external stimulation to perceive the passing of time, causing difficulties in maintaining an internal sense of timing.
In this episode, Jonathan Sackier is joined by Adrian Owen, Professor of Cognitive Neuroscience and Imaging at the University of Western Ontario. They explore Owen's groundbreaking research on consciousness in vegetative states, the ethical questions raised by his work, and the cutting-edge technology that has changed our understanding of the brain. Timestamps: 00:00 – Introduction 02:46 – Taking one album on a desert island 04:03 – A groundbreaking discovery about vegetative states 06:58 – Owen's bestseller: ‘Into the Gray Zone' 11:18 – Where is the border between life and death? 15:40 – Cutting-edge technologies for brain imaging 20:11 – Applications of fMRI and EEG 24:41 – Does brain-training work? 31:09 – Implications for life support and end-of-life care 36:00 – Owen's three wishes for healthcare
Can your hair type really prevent you from participating in neuroimaging research? In this episode, Beverley Isibor sits down with Dwaynica Greaves, a PhD candidate at UCL, to unpack the scope of a research study funded by the Centre for Equality Research in Brain Sciences. Along with the research team, Antonia Hamilton and Isla Jones, Dwaynica discusses how hair types and styles can impact participation. Additionally, they explore why accessibility in research matters, the biases in scientific equipment, and what can be done to make neuroimaging research more inclusive. Transcription link: https://www.ucl.ac.uk/brain-sciences/about-faculty/equality-diversity-and-inclusion/edi-chronicles-brain-sciences-podcast/edi-4 Date of episode recording: 2024-12-09T00:00:00Z Duration: 32:13 Language of episode: English Presenter:Beverley Isibor Guests: Dwaynica Greaves Producer: Teresa Baker
April 1 marks the beginning of Autism Awareness Month in the U.S. and the U.K. so I invited neuroscientist Dr. Gina Rippon on the pod to talk about what autism is, the history of its diagnosis, and how women and girls have been overlooked in autism research.About our guest: Professor Gina Rippon is Professor Emeritus of Cognitive NeuroImaging at Aston University in the UK. Her research involves the use of state-of-the-art brain imaging techniques to investigate developmental disorders such as autism, profiling different patterns of brain activity in autistic children and adults. Her current research explores the under-recognition of autism in women and girls, especially in neuroscience research. Her new book on this topic: The Lost Girls of Autism (UK)/Off the Spectrum (US) is released in April 2025.
In this episode of Talk Nerdy, Cara is joined by cognitive neuroscientist and neuroimaging expert, Gina Rippon. They discuss her forthcoming book (April 1 2025), “Off the Spectrum: Why the Science of Autism Has Failed Women and Girls”, which is a call to recognize the full spectrum of the autistic experience. Follow Gina: @ginarippon1
About our guest:Ilyse Genser is a pediatric neurologist and the associate program director of the pediatric neurology combined residency program at Children's National Hospital. She is originally from Westchester, New York, where she attended medical school at New York Medical College. She then completed her general pediatrics training at Brown University in Providence, Rhode Island, and came to Washington, D.C., to complete her child neurology training at Children's National Hospital. Learning Objective:Develop an expert-guided approach to choosing appropriate neuroimaging techniques for critically ill children.References: Shulman, J. G., & Abdalkader, M. (2023). Imaging of Central Nervous System Ischemia. http://journals.lww.com/continuumHakimi, R. (2023). Imaging of Central Nervous System Hemorrhage. http://journals.lww.com/continuumJordan, J. T., & Gerstner, E. R. (2023). Imaging of Brain Tumors. http://journals.lww.com/continuumBarnette, A. R., Horbar, J. D., Soll, R. F., Pfister, R. H., Nelson, K. B., Kenny, M. J., Raju, T. N. K., Bingham, P. M., & Inder, T. E. (2014). Neuroimaging in the Evaluation of Neonatal Encephalopathy. PEDIATRICS, 133(6), e1508–e1517. https://doi.org/10.1542/peds.2013-4247Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.
About our guest:Ilyse Genser is a pediatric neurologist and the associate program director of the pediatric neurology combined residency program at Children's National Hospital. She is originally from Westchester, New York, where she attended medical school at New York Medical College. She then completed her general pediatrics training at Brown University in Providence, Rhode Island, and came to Washington, D.C., to complete her child neurology training at Children's National Hospital. Learning Objective:Develop an expert-guided approach to choosing appropriate neuroimaging techniques for critically ill children.References: Shulman, J. G., & Abdalkader, M. (2023). Imaging of Central Nervous System Ischemia. http://journals.lww.com/continuumHakimi, R. (2023). Imaging of Central Nervous System Hemorrhage. http://journals.lww.com/continuumJordan, J. T., & Gerstner, E. R. (2023). Imaging of Brain Tumors. http://journals.lww.com/continuumBarnette, A. R., Horbar, J. D., Soll, R. F., Pfister, R. H., Nelson, K. B., Kenny, M. J., Raju, T. N. K., Bingham, P. M., & Inder, T. E. (2014). Neuroimaging in the Evaluation of Neonatal Encephalopathy. PEDIATRICS, 133(6), e1508–e1517. https://doi.org/10.1542/peds.2013-4247Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.
Neuroimaging is a tool to classify and ascertain the etiology of epilepsy in people with first or recurrent unprovoked seizures. In addition, imaging may help predict the response to treatment. To maximize diagnostic power, it is essential to order the correct imaging sequences. In this episode, Aaron Berkowitz, MD, PhD, FAAN speaks with Christopher T. Skidmore, MD, author of the article “Neuroimaging in Epilepsy,” in the Continuum February 2025 Epilepsy issue. Dr. Berkowitz is a Continuum® Audio interviewer and professor of clinical neurology at the University of California, San Francisco Dr. Skidmore is an associate professor of neurology and vice-chair for clinical affairs at Thomas Jefferson University, Department of Neurology in Philadelphia, Pennsylvania. Additional Resources Read the article: Neuroimaging in Epilepsy Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Guest: @ctskidmore Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Christopher Skidmore about his article on neuroimaging in epilepsy, which appears in the February 2025 Continuum issue on epilepsy. Welcome to the podcast, Dr Skidmore. Would you please introduce yourself to our audience? Dr Skidmore: Thank you for having me today. I'm happy to talk to you, Dr Berkowitz. My name is Christopher Skidmore. I'm an associate professor of neurology at Thomas Jefferson University in Philadelphia. I'm a member of the Jefferson Comprehensive Epilepsy Center and also serve as the vice chair of clinical affairs for the department. Dr Berkowitz: Thank you very much for joining us and for this fantastic article. It's very comprehensive, detailed, a very helpful review of the various types of brain pathology that can lead to epilepsy with very helpful images and descriptions of some of the more common findings like mesial temporal sclerosis and some of the less common ones such as cortical malformations, heterotopia, ganglioglioma, DNET. So, I encourage all of our listeners to read your article and take a close look at those images. So, hopefully you can recognize some of these findings on patients' neuroimaging studies, or if you're studying for the right or the boards, you can recognize some of these less common congenital malformations that can present in childhood or adulthood with epilepsy. In our interview today, what I'd like to do is focus on some practical tips to approaching, ordering, and reviewing different neuroimaging studies in patients with epilepsy. So to start, what's your approach when you're reviewing an MRI for a patient with a first seizure or epilepsy? What sequence do you begin with and why, how do you proceed through the different sequences and planes? What exactly are you looking for? Dr Skidmore: It's an important question. And I think to even take a step back, I think it's really important, when we're ordering the MRI, we really need to be specific and make sure that we're mentioning the words seizures and epilepsy because many radiology centers and many medical centers have different imaging protocols for seizure and epilepsy patients as compared to, like, a stroke patient or a brain tumor patient. I think first off, we really need to make sure that's in the order, so that way the radiologist can properly protocol it. Once I get an image, though, I treat an MRI just like I would a CAT scan approach with any patient, which is to always approach it in the same fashion. So, top down, if I'm looking at an axial image. If I'm looking at a coronal image, I might start at the front of the head and go to the back of the head. And I think taking that very organized approach and looking at the whole brain in total first and looking across the flare image, a T2-weighted image and a T1-weighted image in those different planes, I think it's important to look for as many lesions as you can find. And then using your clinical history. I mean, that's the value of being a neurologist, is that we have the clinical history, we have the neurological exam, we have the history of the seizure semiology that can might tell us, hey, this might be a temporal lobe seizure or hey, I'm thinking about a frontal lobe abnormality. And then that's the advantage that we often have over the radiologist that we can then take that history, that exam, and apply it to the imaging study that we're looking at and then really focus in on those areas. But I think it's important, and as I've illustrated in a few of the cases in the chapter, is that don't just focus on that one spot. You really still need to look at the whole brain to see if there's any other abnormalities as well. Dr Berkowitz: Great, that's a very helpful approach. Lots of pearls there for how to look at the imaging in different planes with different sequences, comparing different structures to each other. Correspondent reminder, listeners, to look at your paper. That's certainly a case where a picture is worth a thousand words, isn't it, where we can describe these. But looking at some of the examples in your paper, I think, will be very helpful as well. So, you mentioned mentioning to the neuroradiologist that we're looking for a cause of seizures or epilepsy and epilepsy protocols or MRI. What is sort of the nature of those protocols if there's not a quote unquote “ready-made” one at someone 's center in their practice or in their local MRI center? What types of things can be communicated to the radiologist as far as particular sequences or types of images that are helpful in this scenario? Dr Skidmore: I spent a fair amount of time in the article going over the specific MRI protocol that was designed by the International League Against Epilepsy. But what I look for in an epilepsy protocol is a high-resolution T2 coronal, a T2 flare weighted image that really traverses the entire temporal lobe from the temporal tip all the way back to the most posterior aspects of the temporal lobe, kind of extending into the occipital lobe a little bit. I also want to see a high resolution. In our center, it's usually a T1 coronal image that images the entire brain with a very, very thin slice, and usually around two millimeters with no gaps. As many of our neurology colleagues are aware, when you get a standard MRI of the brain for a stroke or a brain tumor, you're going to have a relatively thick slice, anywhere from five to eight millimeters, and you're actually typically going to have a gap that's about comparable, five to eight millimeters. That works well for large lesions, strokes, and big brain tumors, but for some of the tiny lesions that we're talking about that can cause intractable epilepsy, you can have a focal cortical dysplasia that's literally eight- under eight millimeters in size. And so, making sure you have that nice T1-weighted image, very thin slices with no gaps, I think is critical to make sure we don't miss these more subtle abnormalities. Dr Berkowitz: Some of the entities you describe in your paper may be subtle and more familiar to pediatric neurologists or specialized pediatric neuroradiologists. It may be more challenging for adult neurologists and adult neuradiologists to recognize, such as some of the various congenital brain malformations that you mentioned. What's your approach to looking for these? Which sequences do you focus on, which planes? How do you use the patient 's clinical history and EEG findings to guide your review of the imaging? Dr Skidmore: It's very important, and the reason we're always looking for a lesion---especially in patients that we're thinking about epilepsy surgery---is because we know if there is a lesion, it increases the likelihood that epilepsy surgery is going to be successful. The approach is basically, as I mentioned a little bit before, is take all the information you have available to you. Is the seizure semiology, is it a hyper motor semiology or hyperkinetic semiology suggestive of frontal lobe epilepsy? Or is it a classic abdominal rising aura with automatisms, whether they be manual or oral automatisms, suggesting mesial temporal lobe epilepsy? And so, take that clinical history that you have to help start to hone your eye into those individual locations. But then, once you're kind of looking in these nonlesional cases, you're also then looking at the EEG and where their temporal lobe spikes, where their frontal lobe spikes, you know, using that and pulling that information in. If they saw a neuropsychologist pulling in the information in from the neuropsychological evaluation; if they have severe reductions in verbal memory, you know, focusing on the dominant temporal lobe. So, in a right-handed individual, typically the left temporal lobe. And kind of then really spending a lot of time going slice at a time, very slowly, because in some of these vocal-cortical dysplasias it can be just the blurring of the gray-white margin. What I find easiest is to identify that gray-white margin and almost track it. Like, you use the mouse to kind of track it around and say, can I outline the exact border of the gray white margin in the frontal lobe that I'm interested in or the temporal lobe that I'm interested in, kind of looking for those subtle abnormalities. Often as neurologists, we don't have the luxury of being able to immediately reformat. As I mentioned, our T1 volume acquisition study is done in the coronal plane, but sometimes you might want it in the axial plane. And so, I might reach out to the radiologist and say, hey, can you reformat this in the axial plane because I'm interested in the frontal lobe epilepsy and it's a little bit better at looking at it in that plane? And I'll have them reformat and put it back on the pack so I can look at it in that manner. And so that's a, kind of another strategy is to take what you have, but also then go back to the radiologist and say, I need to look at it this a different way. Can you reformat it for me? Looking for that gray-white matter junction is the nice way to pick up for kind of subtle cortical dysplasias. And then when you see an abnormality, to be able to put the T1, the T2, and the flare image all up next to each other and use the technology built into most of our browsers to put on what's called the localizer mode, where I can highlight a specific spot that I'm seeing on the T1 and then very easily quickly see, what does it look like on the T2? What does it look like on the flare? To kind of quickly decide, is it a true abnormality or am I only seeing it on one slice because of an artifact on that one imaging sequence? And I think that's the biggest kind of key is to make sure, is it an artifact or is it not an artifact? That's kind of the most common thing that we, I think, get confused with. Dr Berkowitz: So, some very helpful pearls there in terms of reviewing the imaging, being in dialogue with our neuroradiology colleagues to think about potentially reacquiring certain images on certain planes or looking at the images with our neuroradiology colleagues to let them know more about the clinical history and where we're sort of zooming in about possible abnormalities. Dr Skidmore: I would just add in there that when looking at especially the mesial temporal structures, because of a lot of artifacts that can be present in an individual MRI machine, it's not uncommon that the mesial temporal structure will appear brighter because of an MRI magnet artifact. And so, it's a good key to look at the hippocampus compared to the insula. And so, the hippocampus and the insula should have similar signal characteristics. You're seeing the hippocampus is bright, but the insula ipsilateral to it's normal intensity. That would suggest that that's probably a true hyperintensity on the flare-weighted image as opposed to if both are bright, unless you're suspecting a hemispheric abnormality, it's more likely to be a kind of artifact in the MRI machine. Dr Berkowitz: Okay. Those are really helpful tips, not just to analyze the hippocampus and medial temporal lobe itself---let's remember our anatomy and the circuit of Papez---and to look at associated structures for supporting evidence of a possible abnormality in the hippocampus itself. It looks like there may be something subtle. We can use some additional information from the image to try to decide if that is real or artifactual, and of course correlating with the clinical picture and EEG. I'd like to talk briefly now about some other imaging modalities that you discuss in your paper, the use of functional imaging such as PET, SPECT and fMRI. Let's talk a bit about each of these. When would you order a PET scan for a patient with epilepsy? What would you be looking for and how would you be using that to make clinical decisions? Dr Skidmore: Yeah, so these functional imaging modalities are really utilized when we're evaluating somebody that's not responding to medications. So, they're medically intractable, and we're wondering, could they be a candidate for epilepsy surgery? And so, most of these imaging modalities are really relegated to the world of epileptologists at surgical epilepsy centers. I wanted to include them, though, in the article because I do think it's important for general neurologists to understand kind of what they are, because invariably a patient sees me and then they go back to their general neurology and be like, hey, Doctor Skidmore said I had this PET scan abnormality. What do you think? So, I think it's a good idea for general neurologists to kind of understand them. So, probably the oldest that we've utilized is the FDG PET scan, basically looking at fluorodeoxyglucose and the brain's utilization of glucose. As we all remember, again, glucose is the primary molecule for energy and ATP production in the brain. And so basically, by injecting radioactive glucose in the interictal state--- so not during a seizure but in between seizures---areas of the brain that are not taking up the radiotracer will show as being hypometabolic. So, low metabolism. And hypometabolic regions in the interictal state have been associated with onset regions for epileptic seizures. Let's say you have a patient clinical history, you think they have temporal of epilepsy, EEG suggests temporal of epilepsy, but the MRI is nonlesional, meaning there's no abnormality that anybody could appreciate even at a 3 Tesla scanner. We'll get an FDG PET scan and see, is there hypo metabolism in that temporal lobe of interest? And if there is, well, that's been shown through several published papers, that's just as valuable as having an abnormality on the MRI. And so, we often again use these PET scans, especially in nonlesional cases, to try to find that subtle cortical dysplasia. Now you have your nice epilepsy protocol MRI, it says it's nonlesional. You get your PET scan, it shows hypometabolism in a region of the frontal lobe, let's say, in a in a frontal lobe epilepsy case. And then often we go back, we kind of talked about strategy of how you find those subtle lesions. Then you go back and say, well, look, this gyrus specifically on the PET scan said it's abnormal. You end up looking for really subtle, very tiny abnormalities that, even with somebody that's skilled, often at first review gets missed. So, that's how we use the PET scan. The SPECT scan is done typically in the ictal state. So, now somebody's in an epilepsy monitoring unit often, where you're injecting radio tracer at the exact moment that somebody starts having a seizure. And we know when there's increased seizure activity, the increased seizure activity---let's say it's from my right temporal lobe---is going to increase cerebral blood flow transiently to the right temporal lobe. And then if that seizure discharge spreads from the right temporal lobe maybe to the entire right hemisphere and eventually becomes a focal to bilateral tonic chronic seizure by spreading to the other side, the entire brain is going to be hypoperfused at that point. So, if you want to, as soon as the seizure starts, inject that radio tracer to see, where is the blood flow earliest in the seizure? And then we might do an interictal SPECT when you're not having a seizure. Look at, all right, what's the normal blood flow when somebody's not seizing? What's it like when they're having a seizure? And then the area that has increased activity would- might suggest that's where the seizure started from. But we have to be very careful because again, some seizures can spread very rapidly. So, if you delay injecting an injection ten, fifteen, twenty seconds, the seizure could have already propagated to another region of the brain, giving you a false positive in another location. So, you have to be very careful about that modality. I think what's most exciting is the functional MRI because the functional MRI, for many, many centers, is replacing a very old technique called the WADA test. So, in the WADA test, typically you place a catheter angiogram into the internal carotid artery and transiently introduce a sedative medication to put, let's say, the left hemisphere to sleep because you wanted to see what functions were still active in the right hemisphere. And then the surgeon would move the catheter or the right internal carotid artery, and you inject a sedative on that side after the left hemisphere is recovered and see what the left hemisphere can do. And we used that for language dominance, we used that for memory dominance. And while most individuals did fine with angiograms, unfortunately complications do occur and there's injury to the artery, there could be strokes that can- that have happened, which can be quite devastating for the patient. And so, functional MRI is a nice, noninvasive way for us to map out language function, motor function, sensory function, visual function, and is starting to show some usefulness also for mapping out kind of memory function, dominant memory function, meaning verbal memory compared to visual memory. To be able to do those things noninvasively becomes really important because, if we're talking about epilepsy surgery, we want to make you seizure-free but neurologically intact. And so, we need to understand the relationship between where we think the seizures are coming from and where eloquent cortex is so we can properly counsel you and avoid those regions during any planned surgery. Those are the three most common functional imaging modalities that we're using now to supplement the rest of the presurgical work. Dr Berkowitz: Very helpful. So, these are studies, PET, SPECT, and fMRI, that would really be obtained predominantly in patients in whom epilepsy surgery was being considered to have more precise lesion localization, as well as with the fMRI to get a better sense of how to provide the safest maximal resection of epileptogenic tissue while preserving functions. Dr Skidmore: That's a perfect summary. Dr Berkowitz: Fantastic. This has been a really helpful interview with Dr Skidmore and a really fantastic article. As I said, a picture is worth a thousand words, so I definitely encourage you to read the article and look at the images of some of the conditions we've been talking about and some of these findings that can be seen on interictal PET or ictal SPECT to get a sense of the visual aspects of what we've been discussing. So again, today I've been interviewing Dr Christopher Skidmore about his article on neuroimaging and epilepsy, which appears in the most recent issue of Continuum on Epilepsy. Be sure to check out Continuum audio episodes from this and other issues. And thank you so much to our listeners for joining us today. Dr Skidmore: Thank you for having me. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.
Transforming healthcare through innovations in extreme environments.Humans operating in extreme environments often conduct their operations at the edges of the limits of human performance. Sometimes, they are required to push these limits to previously unattained levels. As a result, their margins for error in execution are much smaller than that found in the general public. These same small margins for error that impact execution may also impact risk, safety, health, and even survival. Thus, humans operating in extreme environments have a need for greater refinement in their preparation, training, fitness, and medical care. (Source: Optimizing human performance in extreme environments through precision medicine: From spaceflight to high-performance operations on Earth) This session discusses the latest developments in Space & Earth medical science and research with leaders in this specialist, exciting and critically important domain of humans in space. Panelists:Dr Josef Schmid, First Human Holoported to Space | NASA Orion Medical Operations Lead | NASA Flight Surgeon, NASADr Shawna Pandya, First named Canadian female commercial astronaut; Physician & Director, International Institute for Astronautical Sciences Space Medicine GroupEkaterina Kostioukhina, Medical Consultant, Air Ambulance Flight Team, Human hibernation researcher, Health New ZealandVladimir Ivkovic, PhD, Director, Research Opportunities, Center for Space Medicine Research, Department of Psychiatry | Director, Laboratory for Neuroimaging and Integrative Physiology, Neural Systems Group, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School#australiainspacetv #spacemedicine #humansinspace
Dr. Richard Haier is an emeritus professor of Pediatric Neurology at UC Irvine, who spent his career studying the neuroscience of intelligence. Over the course of his career, Haier has come to believe in the existence of a “g-factor,” a measurable quantity of broad spectrum intelligence that is universally predictive of success in all cultures. He also believes that intelligence is a fixed characteristic, and that it's possible to predict someone's intelligence by watching how their brain works when trying to solve a puzzle. We sit down with him to figure out how far one can take this theory of intelligence before running headlong into a heartless social darwinism, why intelligence research feels so creepy, if IQ tests are actually measuring what we think they're measuring, if intelligence is really the thing that we should be optimizing for, and if it's possible for technology to make us dumber. Don't miss the historic cosmology summit in Portugal this summer!!! DEMYSTICON 2025 ANNUAL MEETING June 12-16: https://demystifysci.com/demysticon-2025 PATREON: get episodes early + join our weekly Patron Chat https://bit.ly/3lcAasB MERCH: Rock some DemystifySci gear : https://demystifysci.myspreadshop.com/all AMAZON: Do your shopping through this link: https://amzn.to/3YyoT98 SUBSTACK: https://substack.com/@UCqV4_7i9h1_V7hY48eZZSLw@demystifysci 00:00 Go! 00:09:28 Flynn Effect and G Factor 00:15:40 Testing, Practice, and Intelligence 00:26:58 The Relationship Between Intelligence, Motivation, and Test Scores 00:31:09 Heritability and Societal Implications of Intelligence 00:35:51 The Social Value of Intelligence Versus Athletic Ability 00:41:54 IQ Levels and Educational Attainment 00:48:03 The Dilution of College Degrees 00:53:07 Educational System Critique 00:57:24 Intelligence and Occupational Success 01:01:40 Bureaucracy and Talent in Academia 01:06:13 Intelligence and Personal Success 01:19:20 Enhancing Intelligence through Drugs 01:25:28 Brain Efficiency and Intelligence 01:31:12 Tetris Study and Brain Efficiency 01:44:20 Predicting Intelligence through Brain Imaging 01:49:58 Brain Structure and Cognitive Prediction 01:52:00 Challenges in Enhancing Intelligence 02:04:22 Environmental and Genetic Interplay 02:14:02 Understanding Autism and Intelligence 02:19:56 Artificial Intelligence vs. Human Intelligence 02:28:21 Technology's Impact on Skill Development 02:32:55 Flynn Effect and Educational Implications 02:39:24 Technology and Its Impact on Children 02:45:08 Societal Roles and Intelligence Levels 02:48:09 Meaning and Societal Functionality #IQTests, #Neuroscience, #intelligence, #iqtest, #ArtificialIntelligence, #HumanIntelligence, #CognitiveScience, #BrainFunction, #iq , #Neuroimaging, #AIvsHumans, #TechImpact, #philosophypodcast, #sciencepodcast, #longformpodcast Check our short-films channel, @DemystifySci: https://www.youtube.com/c/DemystifyingScience AND our material science investigations of atomics, @MaterialAtomics https://www.youtube.com/@MaterialAtomics Join our mailing list https://bit.ly/3v3kz2S PODCAST INFO: Anastasia completed her PhD studying bioelectricity at Columbia University. When not talking to brilliant people or making movies, she spends her time painting, reading, and guiding backcountry excursions. Shilo also did his PhD at Columbia studying the elastic properties of molecular water. When he's not in the film studio, he's exploring sound in music. They are both freelance professors at various universities. - Blog: http://DemystifySci.com/blog - RSS: https://anchor.fm/s/2be66934/podcast/rss - Donate: https://bit.ly/3wkPqaD - Swag: https://bit.ly/2PXdC2y SOCIAL: - Discord: https://discord.gg/MJzKT8CQub - Facebook: https://www.facebook.com/groups/DemystifySci - Instagram: https://www.instagram.com/DemystifySci/ - Twitter: https://twitter.com/DemystifySci MUSIC: -Shilo Delay: https://g.co/kgs/oty671
Iain McGilchrist is a Consultant Emeritus of the Bethlem and Maudsley Hospital, London, a former research Fellow in Neuroimaging at Johns Hopkins University Medical School, Baltimore, a former Fellow of All Souls College, Oxford, an Associate Fellow of Green Templeton College, Oxford, a Fellow of the Royal College of Psychiatrists, a Fellow of the Royal Society of Arts, and a former Fellow of the Institute of Advanced Studies in Stellenbosch. He has published original research on neuroimaging in schizophrenia, the phenomenology of schizophrenia, and other topics. Some of his many books include "The Master and his Emissary: The Divided Brain and the Making of the Western World" (2009), The Divided Brain and the Search for Meaning; Why Are We So Unhappy? (2012), and "The Matter with Things: Our Brains, Our Delusions and the Unmaking of the World" (2021). Full Episode: https://www.youtube.com/watch?v=2UEXDs4mouU Title: "Iain McGilchrist: Why Are Our Brains Divided? Hemispheric Differences And Its Impact On The Mind" CONNECT: - Website: https://tevinnaidu.com - Podcast: https://creators.spotify.com/pod/show/mindbodysolution - YouTube: https://youtube.com/mindbodysolution - Twitter: https://twitter.com/drtevinnaidu - Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu - LinkedIn: https://linkedin.com/in/drtevinnaidu ============================= Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.
This week, we are joined by Anila D'Mello, an assistant professor at UT Southwestern, whose groundbreaking research uses neuroimaging to explore the brain circuits that support language and cognition in autism. Dr. D'Mello will share insights from her work on cerebro-cerebellar circuits and how they differ in neurodevelopmental disorders. Join us as we discuss how these findings can transform our understanding of autism and inform future interventions. Download episode to learn more! Resources A seat at the (language) table: incorporating the cerebellum into frameworks for language processingLeBel, A., D'Mello, A.M Current Opinion in Behavioral Sciences 2024 Exclusion of females in autism research: Empirical evidence for a "leaky" recruitment-to-research pipeline.D'Mello AM, Frosch IR, Li CE, Cardinaux AL, Gabrieli JDE, Autism Res 2022 Aug Cerebellar Contributions to Social Cognition in ASD: A Predictive Processing Framework.Frosch IR, Mittal VA, D'Mello AM, Front Integr Neurosci 2022 16 810425 Enhanced rationality in autism spectrum disorder.Rozenkrantz L, D'Mello AM, Gabrieli JDE, Trends Cogn Sci 2021 08 25 8 685-696 Differential Behavioral and Neural Effects of Regional Cerebellar tDCS.Rice LC, D'Mello AM, Stoodley CJ, Neuroscience 2021 05 462 288-302 Anxiety, Motivation, and Competence in Mathematics and Reading for Children With and Without Learning Difficulties.Pollack C, Wilmot D, Centanni TM, Halverson K, Frosch I, D'Mello AM, Romeo RR, Imhof A, Capella J, Wade K, Al Dahhan NZ, Gabrieli JDE, Christodoulou JA, Front Psychol 2021 12 704821 ............................................................... Autism weekly is now found on all of the major listening apps including apple podcasts, google podcasts, stitcher, Spotify, amazon music, and more. Subscribe to be notified when we post a new podcast. Autism weekly is produced by ABS Kids. ABS Kids is proud to provide diagnostic assessments and ABA therapy to children with developmental delays like Autism Spectrum Disorder. You can learn more about ABS Kids and the Autism Weekly podcast by visiting abskids.com.
Neuroimaging is an essential tool in diagnosing and managing complex auditory and vestibular conditions, and the new textbook 'Neuroimaging of the Auditory and Vestibular Systems: A Clinician's Guide' is designed to equip healthcare professionals with the knowledge needed to excel in this field. In this discussion, Dr. Matthew Bush, otolaryngologist and department chair at the University of Kentucky, highlights the book's multidisciplinary approach, combining perspectives from audiology, radiology, and otology to provide a comprehensive resource for clinicians. The text systematically explores the anatomy, pathology, and imaging findings of the auditory and vestibular systems, offering practical insights for identifying and managing complex conditions. As audiologists in some states gain the ability to order imaging, this book becomes increasingly relevant for professionals aiming to meet the evolving demands of patient care. By bridging gaps between disciplines, the textbook promotes collaborative communication and enhances diagnostic accuracy. Dr. Bush also discusses the broader importance of integrating neuroimaging into clinical practice, not just for all healthcare providers involved in hearing and balance care. For more information on the new textbook, visit: https://www.pluralpublishing.com/publications/neuroimaging-of-the-auditory-and-vestibular-systems-a-clinicians-guide Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter): https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing
In this interview with Dr. Bret Scher, Dr. Corinde Wiers, Assistant Professor of Psychiatry at the University of Pennsylvania, unveils her groundbreaking research on using ketogenic therapy to treat alcohol use disorder (AUD). Dr. Wiers dives into how ketones, as an alternative energy source, may alleviate withdrawal symptoms, reduce cravings, and transform the landscape of addiction recovery. This conversation covers: The science of brain energy metabolism and how ketones are preferred over glucose in AUD. Results from clinical trials, including reductions in withdrawal severity and the need for benzodiazepines. Neuroimaging data that shows how ketogenic diets affect the brain's reward system and craving mechanisms. The broader implications of metabolic therapies for treating mood disorders, addiction, and brain health. Dr. Wiers shares her journey from studying alcohol use disorders in Europe to leading cutting-edge research in the U.S. She provides insights into the challenges and opportunities of integrating metabolic therapies into mainstream mental health and addiction treatment. Experts Featured Dr. Corinde Wiers X: @CorindeW LinkedIn: https://www.linkedin.com/in/corinde-wiers-479a9219/ https://www.med.upenn.edu/csa/corindewiers.html Resources: Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents https://pubmed.ncbi.nlm.nih.gov/33837086/ Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/ About us: Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #MetabolicNeuroscience #KetogenicMetabolicTherapy #NutritionalKetosis #AlternativeTreatment #PsychiatricMedication#KetogenicTherapy #KetoforAlcoholUseDisorder #AlcoholUseDisorder
Send us a textAbout the guest: Joshua Siegel, MD, PhD is a psychiatrist & systems neuroscience at New York University. He uses functional imaging to study the effects of psychedelics and other drugs on the human brain.Episode summary: Nick and Dr. Siegel discuss: fMRI and how it works; relationship between neural activity and blood flow; functional connectivity & the default mode network of the human brain; the functional effects of psilocybin on the brain; the role that subjective & expectancy effects in psychedelics medicine; and more.Related episodes:M&M #173: Psychedelics, Consciousness, Psychiatry, Psychology, Mental Health & the Entropic Brain HypothesisM&M #163: Anesthesia, Placebo Effects, Consciousness, Subjectivity, MDMA, Ketamine, Opioids, Psychedelics*This content is never meant to serve as medical adviceSupport the showAll episodes (audio & video), show notes, transcripts, and more at the M&M Substack Affiliates: MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils, artificial ingredients, etc. Use code MIND for 20% off. SiPhox Health—Affordable, at-home bloodwork w/ a comprehensive set of key health marker. Use code TRIKOMES for a 10% discount. Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off. Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase. Consensus: AI-powered academic research tool. Find & understand the best science, faster. Free 1-year premium sub with code MINDMATTERSPECIAL Learn all the ways you can support my efforts
Today our guest is Dr. Angie Laird, who trained as an imaging physicist, but has evolved into a cognitive neuroscientist and a true pioneer in meta-analysis of fMRI data. Dr. Laird has spent the bulk of her career developing novel data analysis algorithms, neuroscience informatics tools, and neuroimaging ontologies to yield analytic strategies for improving investigations into functional brain networks of healthy individuals as well as in populations with psychiatric and neurologic diseases and disorders. Early on she has seen the untapped value in meta-analysis, and has fostered growth in this fundamentally important area in functional brain imaging. Dr. Laird received her B.S. in Physics from Florida State University in 1998, and her Ph.D. in Medical Physics from the University of Wisconsin-Madison in 2002. She was a faculty member at the Research Imaging Institute of the University of Texas Health Science Center in San Antonio from 2004-2012, and currently she is Professor and Director for Imaging Science at Florida International University in Miami. Along with her development of meta-analysis tools and her own research, she plays a central role in the Adolescent Brain Cognitive Development (ABCD) consortium which is the largest long-term study of brain development and child health in the United States. This was a great conversation that spanned the early culture of fMRI research, early efforts towards data sharing, to the current practices today where data sharing and analyzing data across studies and from large shared datasets is becoming the norm. We also spent time talking about the origin, logistics, and impact of the ABCD project. We hope you enjoy it! Episode producers: Omer Faruk Gulban Xuqian Michelle Li
Explore the science and potential of hypnosis as Dr. David Spiegel, Stanford's leading expert in mind-body medicine, joins Dave Asprey to reveal how hypnosis can radically enhance cognition, mental clarity, and resilience. In this episode of The Human Upgrade, you'll learn how hypnosis influences the brain's most vital networks, including the default mode network and executive control, to break mental barriers and amplify focus, perception, and healing. Discover how hypnosis, unlike traditional meditation or neurofeedback, accelerates response times, manages pain, and even helps alleviate PTSD. Dr. Spiegel shares stories of patients overcoming chronic pain and trauma through self-hypnosis, and details the mechanisms that make hypnosis a powerful tool for emotional and physical transformation. Dive into the fascinating brain science behind the practice, from theta brainwave induction to deep sensory modulation, and learn simple self-hypnosis techniques that can elevate mental performance, improve sleep quality, and instill lasting calm. If you're seeking a powerful, accessible way to biohack your brain and harness the potential of your mind, this episode delivers the insights and tools you need to make hypnosis your ultimate cognitive upgrade. Sponsors Quantum Upgrade | Go to Quantum Upgrade | Go to https://quantumupgrade.io/Dave for a free trial. Zbiotics | Go to https://zbiotics.com/DAVE for 15% off your first order. Resources: • Dr. David Spiegel's Website – https://med.stanford.edu/profiles/david-spiegel • Reveri Hypnosis App – https://reveri.com (available on App Store and Google Play) • Dave Asprey's Website – https://daveasprey.com • Danger Coffee – https://dangercoffee.com • Danger Coffee Instagram – https://www.instagram.com/dangercoffeeofficial/ • Dave Asprey's Linktree – https://linktr.ee/daveasprey • Dave Asprey's Book: Smarter Not Harder – https://daveasprey.com/books • Upgrade Collective: Join The Human Upgrade Podcast Live – https://www.ourupgradecollective.com • Own an Upgrade Labs – https://ownanupgradelabs.com • Upgrade Labs – https://upgradelabs.com • 40 Years of Zen – Neurofeedback training for advanced cognitive enhancement https://40yearsofzen.com Timestamps • 00:00 – Introduction to Hypnosis • 00:59 – Dave Asprey Introduces Dr. David Spiegel • 02:03 – Dr. Spiegel's Journey into Hypnotherapy • 06:06 – The Power of Hypnosis in Medical Practice • 11:19 – Understanding Hypnosis and Brain Function • 16:14 – Hypnosis for PTSD and Trauma • 19:33 – Hypnosis vs. EMDR: Key Differences • 22:30 – Pain Management through Hypnosis • 31:06 – The Impact of Psychedelics on Cancer Patients • 33:04 – Exploring Psychedelic-Assisted Neurofeedback • 34:05 – Neuroimaging and Brain Activity in Hypnosis • 35:22 – Hypnosis and Cognitive Enhancement • 38:53 – Hypnosis for Sleep and Stress Management • 42:26 – Hypnosis and the “Manchurian Candidate” Concept • 48:21 – Hypnosis and the Immune System • 53:11 – Live Hypnosis Session with Dave Asprey • 58:46 – Conclusion and Final Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr Shane, Dr Lauren, Dr Suzie, and Dr Grazie are joined by Dr Emma Macdonald-Laurs, who is a paediatric neurologist and epileptologist from the Royal Children's Hospital and clinician-scientist fellow at the Murdoch Children's Research Institute to discuss her PhD from the University of Melbourne which explored imaging, treatment and network features of focal cortical dysplasia a major cause of epilepsy in children. She is particularly interested in surgically-remediable epilepsies, neuroimaging and artificial intelligence. The team also spoke to Monika Zabinskas, Life Sciences Manager of the Carnivores & Reptile team Healesville Sanctuary. Monika studied Zoology at university, and has worked for Zoos Victoria for 15 years. Monika has a strong focus on endangered species and is particularly interested in protecting Tasmanian Devils into the future. She also manages the stud book for the species tracking breeding between animals.Program page: Einstein-A-Go-GoFacebook page: Einstein-A-Go-GoTwitter: Einstein-A-Go-Go
In this inaugural episode of our mini-series on brain-computer interfaces, we are joined by Rafael Yuste. Dr. Yuste is Professor of Biological Sciences and Neuroscience at Columbia University, where he directs the Neurotechnology Center. Dr. Yuste is known for his pioneering work on neural circuits and the development of cutting-edge neural imaging techniques, like two-photon calcium imaging. He also co-founded the NeuroRights Foundation to promote and protect neurorights such as mental privacy and cognitive liberty, and was one of the originators of the BRAIN Initiative, a large-scale scientific effort launched by the U.S. government in 2013 to advance understanding of the human brain. In this episode, we talk to Dr. Yuste about some of his empirical work, as well as his work related to neurorights advocacy and the BRAIN Initiative.
In this groundbreaking episode, we explore the rapidly evolving field of psychedelic-assisted therapy with Dr. Paul Liknaitzky, a leading researcher at the forefront of this innovative approach to mental health treatment. From the original and sometimes controversial studies of the 1960s to cutting-edge clinical trials today, we explore how substances once associated with counterculture are now at the forefront of mental health treatment. Dr. Liknaitzky reveals the fascinating synergy between psychedelics and psychotherapy, explaining why this combination holds such promise for treating depression, PTSD, and other mental health disorders. He discusses the latest findings on psilocybin, DMT, and MDMA, examining their unique properties and the scientific rationale behind their use in clinical settings. Through a blend of scientific evidence, real-world examples, and thoughtful analysis, we navigate the complex landscape of regulatory challenges, brain imaging advancements, and the future directions of psychedelic studies. Dr. Liknaitzky also addresses common misconceptions, emphasising the importance of controlled environments and professional guidance in this field. Whether you're a healthcare professional seeking to understand emerging treatments, someone curious about alternative approaches to mental health, or simply interested in the latest developments in psychology, this episode offers a balanced, informative look at a field that could significantly impact our approach to mental health care in the coming years. Key Topics: Historical context: Psychedelic studies from the 1960s to present The synergy of psychedelics and psychotherapy in treatment Importance of combining psychedelics with therapy for effective treatment Regulatory challenges: Recent FDA decisions on psychedelic treatments Ongoing research: Focus on psilocybin and future studies Exploring DMT: Differences from traditional formulations Promising psychedelics for treating depression Brain imaging in psychedelic research: Using fMRI to track changes Future directions in psychedelic studies Potential impact of psychedelic therapy on relationships and family dynamics Actionable Takeaways: The effect of psychedelics is intensified by psychotherapy through a psychotherapeutic process. A productive and successful psychotherapy requires deep trust between patient and therapist. Having your own psychedelic experience potentially improves your competency to be a good psychedelic therapist. We should try to remain in conversation with reality. The critical thing to remain in a relationship with is the reality of real people's lives as we treat them after we treat them. Psilocybin is a promising drug for psychedelic treatment of depression. MDMA is an empathogen that massively increases tolerance for distress and allows you to feel incredibly comfortable. Neuroimaging studies with Psilocybin and LSD cause our default mode network to get quiet. Connect with Paul Liknaitzky: Website: https://www.monash.edu/psychedelics LinkedIn: https://www.linkedin.com/in/paul-liknaitzky-phd-6a2681aa/ Support the Podcast:If you found this episode valuable, please consider subscribing, rating, and leaving a review on your preferred podcast platform. Your support helps us reach more people with important conversations like this one. Share this episode with someone who might benefit from hearing it—emotional eating is more common than we think, and this conversation could make a difference in someone's life.See omnystudio.com/listener for privacy information.
Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sponsored by GE HealthCare.
Diagnosing Amyotrophic Lateral Sclerosis (ALS) at an early stage is a daunting challenge that often seems almost impossible. However, the pressing need for early diagnostic tools has driven remarkable individuals to seek innovative solutions. One such individual is Dr. Ahmadreza Keihani, whose personal story and profound loss led him on a mission to find early diagnostic possibilities for ALS using cutting-edge neurotechnologies. Dr. Keihani, a Postdoctoral Associate at the University of Pittsburgh, brings a wealth of experience and dedication to his work. After graduating as the valedictorian from the medical school at Tehran University of Medical Sciences (TUMS), he was invited to be an assistant professor of neuroimaging. However, driven by a relentless desire to learn and innovate, he moved to the United States to further his research under the mentorship of senior scientists in the field. In this episode, we delve into Dr. Keihani's groundbreaking project, which he developed alongside his colleagues at the University of Pittsburgh and TUMS. Their real-time monitoring system for the cortico-muscular coupling index (CMC) promises to be an early biomarker for ALS, offering hope for earlier diagnosis and intervention. This project was nominated for the prestigious BCI Award 2023, recognizing its potential to revolutionize ALS diagnostics. Dr. Keihani discusses his innovative research and also shares his personal career journey, providing invaluable career advice for aspiring scientists. Additionally, he offers useful information about the International BCI Award application process, giving listeners a behind-the-scenes look at what it takes to submit a successful project. Moreover, Dr. Keihani is an amazing educator, and listeners will truly enjoy his easy-to-understand explanations of complex concepts in neurotech research. Join us as Dr. Keihani shares his journey, the inspiration behind his work, and the innovative neurotechnologies driving his research. We'll explore how his project aims to provide real-time assessment of CMC in ALS patients and the potential impact this could have on the future of ALS diagnosis and treatment. Tune in to discover the intersection of personal passion and scientific innovation with Dr. Ahmadreza Keihani and learn how his work paves the way for new diagnostic possibilities in the fight against ALS. International BCI Award: The International BCI Award sponsored by g.tec medical engineering GmbH is back! If you're working on pioneering BCI research, use your chance to gain international recognition. With a total endowment of $6,000 USD and the possibility of publishing and presenting your work globally, this is an opportunity to shine at the forefront of neuroscience innovation. Submission Deadline: September 1st, 2024 Nominees will be invited to: Submit a chapter for the BCI State-of-the-Art book series by Springer. Present their work at the prestigious BCI Award Ceremony. Receive keynote invitations to the BCI & Neurotechnology Spring School. For more details on submission and criteria, visit: https://www.bci-award.com Join the BCI Award Ceremony! About the Podcast Guest: Ahmadreza Keihani, PhD graduated with a BSc in Biomedical Engineering (Bioelectric) from Isfahan University in 2014 and completed his MSc and PhD in the same field at Tehran University of Medical Sciences (TUMS), graduating as valedictorian in 2022. He was then invited to be an assistant professor of neuroimaging at TUMS but moved to the US in 2022 to learn more and work as a postdoctoral associate in the Department of Psychiatry at the University of Pittsburgh, focusing on computational neuroscience. Ahmadreza's research interests include neuroimaging, nonlinear dynamics, biomedical data science, and brain-computer interfaces (BCI). His PhD work on cortico-muscular coupling in ALS patients was nominated for the 2023 BCI Award. He is dedicated to translational research on neurological and psychiatric disorders, with a special focus on causal machine learning. Link to the review BCI paper mentioned in the podcast interview: https://www.mdpi.com/1424-8220/12/2/1211_2 Link to the work discussed in the podcast interview: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0270757 About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news
Auckland neurologist Dr Ray Bose specialises in migraine and says some of the brain changes being identified can be reversed by medications targeting a key neurotransmitter in the brain.
Wir alle wissen inzwischen, dass dauerhafter Stress nicht nur nervt, sondern auch krank macht. Aber wie genau übt man, damit anders umzugehen, ruhiger zu werden, das Leben und sich selbst anders zu betrachten, mit etwas Abstand? Zum Beispiel durch einen MBSR Kurs. Was das ist?Um diese und noch viele andere Fragen zu beantworten, hat Julia sich heute Dr. Britta Hölzel eingeladen. Sie ist Psychologin, Yogalehrerin und Meditationsforscherin und arbeitete unter anderem an der Harvard Medical School in Boston, einem weltweiten Zentrum der Meditationsforschung. In ihrer Doktorarbeit am Bender Institute of Neuroimaging der Universität Gießen konnte sie auf Hirnscans erstmals zeigen, wie regelmäßige Besinnung das Gehirn verändert. Heute ist sie unter anderem auch Expertin für Mindfulness Based Stress Reduction, kurz und besser bekannt als MBSR, einem standardisierten Achtsamkeitskurs zur Stress-Reduktion und Burnout-Prävention, dessen Besuch viele Krankenkassen bezuschussen. ZITAT: „Mindfulness-Based-Stress-Reduction (MBSR), ein standardisiertes Achtsamkeitstraining, ist ein wirksamer Weg aus der Stress-Spirale; Studien zeigen das eindeutig, und deshalb wird der Kurs auch von Krankenkassen bezuschusst.“https://www.brittahoelzel.de+++ Weitere Infos zu unseren Werbepartnern finden Sie hier: https://linktr.ee/menoanmich +++UND HIER GIBT ES WEITERE TOLLE ANGEBOTE ZUR LEBENSMITTE aus der BRIGITTE Redeaktion:NEU On Demand Video-Kurs zum Thema Wechseljahre - sichere dir den Frühstarter-Rabatt bis Ende Juli!Ausserdem, fundierte schriftliche Dossiers zu den ThemenWECHSELJAHRESTOFFWECHSELPARTNERSCHAFT Ihr habt Anregungen, wollt uns Eure Geschichte erzählen oder selbst bei uns zu Gast im Podcast sein? Dann schreibt uns beiden persönlich, worüber Ihr gern mehr wissen würdet, was Euch bewegt, rührt, entsetzt und Freude macht an podcast@brigitte.de. Wir freuen uns auf Euch! Und bewertet und abonniert unseren Podcast gerne auch auf Spotify, iTunes, Amazon Music oder Audio Now. Noch mehr spannende Beiträge findet Ihr zudem auf Brigitte.de sowie dem Instagram- oder Facebook-Account von BRIGITTE –schaut vorbei! Unsere allgemeinen Datenschutzrichtlinien findet Ihr unter https://datenschutz.ad-alliance.de/podcast.htmlUnsere allgemeinen Datenschutzrichtlinien finden Sie unter https://art19.com/privacy. Die Datenschutzrichtlinien für Kalifornien sind unter https://art19.com/privacy#do-not-sell-my-info abrufbar.
Dr. Michele Matarazzo interviews Dr. Jacy Parmera about her recently published article on the clinical and neuroimaging characteristics of patients with corticobasal syndrome, with a focus on the potential correlation with the underlying neuropathological causes. Read the article »
Imagine unlocking a superpower hidden within your mind. Imagine feeling in control of how you engage with the world, how you heal and grow, and how you manage stress. If you're a TBMer, you already know how powerful hypnosis can be, but today we're giving you a fascinating conversation with Dr. David Spiegel, a leading expert in the field of hypnosis and neuroscience. Dive into the incredible world of the mind, where the brain's power to alter perception unfolds before your eyes. Dr. Spiegel shares captivating insights from his groundbreaking research, revealing how hypnosis can create cognitive flexibility, enhance focus, and even facilitate rapid healing. Discover the awe-inspiring potential of your mind to transform your life through practical, science-backed techniques. From personal anecdotes to revolutionary studies, this episode promises to ignite your curiosity and inspire you to harness the full power of your mind. Join us for an extraordinary journey into the wonders of hypnosis and its impact on the mind-body connection. **Trigger Warning: discussion about traumatic event (00:22:10 through 00:22:58)** Find the Complete Show Notes Here -> https://tobemagnetic.com/expanded-podcast In This Episode We Talk About:The role of hypnosis in altering perception and managing painDr. Spiegel's background and family history in psychiatryNeuroimaging studies on the effects of hypnosis on the brainThe significance of the default mode network in hypnosisDissociation and its impact on focus and attentionCognitive flexibility and its benefits in hypnosisHypnosis for managing chronic pain and reducing opioid dependencyFunctional connectivity in the brain during hypnosisThe role of the anterior cingulate cortex in hypnosisHypnosis for stress management and enhancing sleep qualityHypnotic induction techniques and their applicationsThe connection between hypnosis and neuroplasticityPractical applications of hypnosis in daily lifeThe Reveri app and its functionalitiesDr. Spiegel's personal experiences with hypnosis THEMES / TIME STAMPS:Neuroimaging and brain activity during hypnosis (00:13:30)**Trigger Warning: discussion about traumatic event (00:22:10 through 00:22:58)**How hypnosis can be used to manage chronic pain, reduce anxiety, improve sleep, and support personal growth, with real-life examples and clinical trial results. (00:38:45)Unpacking perceived helplessness, and cognitive flexibility (00:55:40)Resources: TBM SUMMER SALE ☀️LIVE NOW Get the lowest prices of the season and up to $96 off 2024 TBM Summer Challenge - Get Out of Your Own WayLIVE NOW - Join anytime Share your challenge manifestations stories for a chance to be featured on The Expanded Podcast Bon Charge - 15% off with code MAGNETICRed Light Face MaskRed Light Neck and Chest Mask BITE - 20% off your first order with code MAGNETICFresh mint toothpaste bits Learn about effectivity of hypnosis on pain management hereLearn about effectivity of hypnosis on quitting smoking hereLearn about our Challenge more in this episodeFind the Safety DI and all workshops mentioned inside our Pathway Membership! (Including all of our Unblocked DIs) Connect with Dr. SpiegelConnect with Dr. Spiegel + Reveri on IGGo to https://www.reveri.com/ to sign up for the app, and be sure to use the exclusive code EXPANDED for 20% off. Where To Find Us!@tobemagnetic (IG)@Lacyannephillips@Jessicaashleygill@tobemagnetic (youtube)@expandedpodcast Other ResourcesSubmit to Be a Process GuestText Us: +1-213-423-5226 - (texting is only for US, Canada, & Puerto Rico)Alexis Smart x TBM EXPANDED Flower RemedyDid you Finish the Manifestation Challenge? Share your experience with us! Free Offerings to Get You StartedLearn the Process! Expanded Podcast - How to Manifest Anything You Desire Get Expanded! The Motivation - Testimonial LibraryNeed Help Identifying Your Block? Access our FREE Find Your Biggest Block Exercise
Dr. Vince Calhoun is the founding director of the tri-institutional center for translational research in Neuroimaging and Data Science (TReNDS) which is a consortium formed by Georgia State University, Georgia Tech, and Emory University. In this part 2 of Peter and Vince's discussion, they dive further into addressing the challenges that fMRI and other modalities face in finding useful information about psychiatric disorders that can be used clinically. They talk about what neuroimaging has taught us about schizophrenia, as well as the goals and challenges of establishing clinical relevance. They also talk a bit about the importance of a data driven approach to development of processing methods, as well as variability in fMRI data, and the challenges and opportunities that big data sets offer, the promise of data fusion, and multivariate modeling. Lastly, they also discuss his latest work in deep learning and what it offers, and spend quite a bit of time discussing data driven approaches vs model driven approaches. This discussion was an outstanding perspective builder. We hope that you enjoy it! Episode producers: Omer Faruk Gulban Xuqian Michelle Li
(0:50) - All The Brain Chip Implant Benefits & None of The SurgeryBecome a founding reader of our newsletter: read.thenextbyte.com
Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients: analysis of UK Biobank The American Journal of Geriatric Psychiatry In this cohort study, researchers examine the association between regular opioid use in patients with chronic pain and development of dementia over 15 years of follow-up. Regular opioid use versus non-opioid analgesic use in this population was associated with increased risk of incident dementia (HR=1.18 CL,1.08-1.30). In addition, there appeared a dose-dependent response with those receiving more prescriptions being more likely to develop dementia: 1-5 prescriptions OR=1.21, 6-20 prescriptions OR=1.27, and >20 prescriptions OR=1.43. Finally, in brain imaging, those with regular opioid use exhibited lower total gray matter and higher white matter hyperintensities. While additional research may be needed to support causality, the authors suggest these findings support caution in regular use of opioids for chronic pain. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM
On popular demand, we invited Dr. Andreas Charidimou once again, to discuss amyloid spells or Cerebral Amyloid Angiopathy-related Transient Focal Neurological Episodes (CAA-TFNEs)What are amyloid spells and its suggested pathophysiology? What are some of its differentials?Clinical features of TIA vs TFNE How many TIAs are really CAA-TFNEs? Who to start on anti-seizure meds and how long do you continue?Neuroimaging findings and when to repeat imaging?Possible relationship with Amyloid-related imaging abnormalities (ARIA) All this and more! Tune in now!You can find Dr. Charidimou on Twitter/X at @a_charidimou or email him at antreas.charidimou@bmc.org Check out our website at www.theneurotransmitters.com to sign up for emails, classes, and quizzes! Would you like to be a guest or suggest a topic? Email us at contact@theneurotransmitters.com Follow our podcast channel for The Neurotransmitters @neuro_podcast for future news! Find me on Twitter @DrKentris (https://twitter.com/DrKentris) The views expressed do not necessarily represent those of any associated organizations. The information in this podcast is for educational and informational purposes only and does not represent specific medical/health advice. Please consult with an appropriate health care professional for any medical/health advice.
Utah patients and caregivers have a chance to learn about the latest therapies and treatments for Alzheimer's disease at a free Alzheimer's Educational Conference on May 15th in West Valley City, Utah. The conference, hosted by the Alzheimer's Foundation of America, will feature experts in the field of Alzheimer's disease, brain health, caregiving, and advanced planning. In this episode of Utah Weekly Forum, FM100.3 Host Rebecca Cressman is joined by Alzheimer's Foundation of America President/CEO Charles J. Fuschillo, Jr and two Utah Alzheimer's experts who will speak about the progress physicians and researchers are making at the upcoming conference: Dr. Christine J Cliatt Brown, a Behavioral Neurologist within University of Utah's Department of Neurology who diagnoses and treats various types of dementia, and Dr. Donna Cross, a Research Associate Professor within University of Utah's Department of Radiology where she heads the Neuroimaging and Biotechnology Laboratory. The conference is open to everyone. To register, visit www.alzfdn.org/tour.
Host Dr. Lily Wang and guest Dr. Alisa Kanfi discuss an article about Neuroimaging of Neonatal Stroke focusing on venous strokes. Neuroimaging of Neonatal Stroke: Venous Focus. Lai et al. RadioGraphics 2024; 44(2):e230117.
Join Christy for 12 papers from January 2024 on structural neuroimaging in the diagnosis of Alzheimer's disease. This episode is a bit different from past ones because it's all about the use of machine learning and deep learning. Whether you're an AI researcher or simply curious about the topic, you won't want to miss this episode. Detecting AD (3:42) Predictions, associations or comparisons (16:48)-------------------------------------------------------------- You can find the bibliography for this episode here, or by clicking the link below:https://drive.google.com/file/d/1A4HZVCtgh5AwZkd5V2ATZSFAxGJt48q3/view?usp=drive_linkTo access the folder with ALL our bibliographies, follow this link (it will be updated as we publish episodes and process bibliographies), or use the link below:https://drive.google.com/drive/folders/1bzSzkY9ZHzzY8Xhzt0HZfZhRG1Gq_Si-?usp=sharingYou can also find all of our bibliographies on our website: amindr.com. -------------------------------------------------------------- Follow-up on social media for more updates!Twitter: @AMiNDR_podcastInstagram: @AMiNDR.podcastFacebook: AMiNDR Youtube: AMiNDR PodcastLinkedIn: AMiNDR PodcastEmail: amindrpodcast@gmail.com -------------------------------------------------------------- Please help us spread the word about AMiNDR to your friends, colleagues, and networks! And if you could leave us a rating and/or review on your streaming app of choice (Apple Podcasts, Spotify, or wherever you listen to the podcast), that would be greatly appreciated! It helps us a lot and we thank you in advance for leaving a review! Don't forget to subscribe to hear about new episodes as they come out too. Thank you to our sponsor, the Canadian Consortium of Neurodegeneration in Aging, or CCNA, for their financial support of this podcast. This helps us to stay on the air and bring you high quality episodes. You can find out more about the CCNA on their website: https://ccna-ccnv.ca/. Our team of volunteers works tirelessly each month to bring you every episode of AMiNDR. This episode was scripted and hosted by Christy Yu, edited by Michelle Grover, and reviewed by Anusha Kamesh. The bibliography and wordcloud were created by Salodin Al-Achkar (www.wordart.com). Big thanks to the sorting team for taking on the enormous task of sorting all of the Alzheimer's Disease papers into episodes each month. For January 2024, the sorters were Elyn Rowe, Christy Yu, Salodin Al-Achkar, Naila Kuhlmann, Yonjoon Shin, Ali Mithani, and Ben Cornish. Also, props to our management team, which includes Sarah Louadi, Ellen Koch, Naila Kuhlmann, Elyn Rowe, Anusha Kamesh, Lara Onbasi, Joseph Liang, Judy Cheng, and Christy Yu, for keeping everything running smoothly. AMiNDR was founded in 2020 by Sarah Louadi, Ellen Koch, Elyn Rowe, and Naila Kuhlmann. Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic. https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w -------------------------------------------------------------- If you are interested in joining the team, send us your CV by email. We are specifically looking for help with sorting abstracts by topic, abstract summaries and hosting, audio editing, creating bibliographies, and outreach/marketing. However, if you are interested in helping in other ways, don't hesitate to apply anyways. --------------------------------------------------------------*About AMiNDR: * Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!"
Traumatic brain injury is one of the leading causes of disability in the United States, and 80% of traumatic brain injuries are classified as ‘mild.' But, these can have serious and long-lasting effects. Dr Jacyln Stephens, Associate Professor in Health and Exercise Science at Colorado State University specialises in brain injury, rehabilitation, and neuroscience. She discusses her research into the injuries of student athletes who are particularly prone to mild traumatic brain injury, and how research is helping to improve both diagnosis and recovery. Read the original research: doi.org/10.3390/brainsci13101413 Find out more on Google Scholar and Pub Med
The University of Chicago Assistant Professor Wilma A. Bainbridge, from the Department of Psychology, leads the Brain Bridge Lab, which focuses on examining the bridge between perception and memory, through the lens of psychophysical experiments, neuroimaging, and drawing studies. In this episode, she talks about her undergraduate experience as a professional guinea pig, studying abroad in Japan, learning languages, and finding her way to researching memory. Professor Bainbridge's career path to becoming a University of Chicago professor continues to evolve as she grows in her multiple roles as a mentor, researcher, mother, and many more.
Are you curious about the truth or myth in the differences between male and female brains? We had the opportunity to speak with Professor Gina Rippon Emeritus Professor of Cognitive Neuroimaging at the Aston Brain Centre, Aston University. She is the past President of the British Association of Cognitive Neuroscience, and her research involves state-of-the-art brain imaging techniques to investigate developmental disorders such as autism especially regarding unrecognized females on the autistic spectrum. Her research also involves the use of neuroscience techniques to explore social processes, particularly those associated with sex/gender issues. She is a passionate supporter of initiatives to address the underrepresentation of women in all spheres of influence, especially science, and advocates an understanding of ‘the neuroscience of belonging' as a framework to address the gender gaps. She is the author of “ Gender and Our Brain”. During our conversation, we discuss the myths associated with brain differences or the lack of them and how 18th-century beliefs have continued to the present day with little progress in shifting the thinking around our brains. It was positioned for men to be seen as superior and women inferior. We still see in today's world that most CEOs are men and that fewer women are representatives in positions of power. She clarifies that there is overlap in research data to point to the minimal differences in male and female brains but our environment plays a significant role in how our brains are developed. Whether that be starting as young as a newborn baby and how we condition the baby to engage with society. She cautions us to pay attention to our definitions and language as we speak about even things like the gender pay gap which are sex gaps. How boys are taught to be brave, and girls are taught to be perfect, these beliefs carry forward into how our lives are shaped and even in more progressive countries where there is still a little impact in more women working in the sciences, mathematics, technology, etc. And finally, the elephant in the room is around AI, and how that will impact our society going forward. Without having more women and diversity engaging in the setup, design, input, and sharing of their personal experiences – we are in for a bigger challenge that will set us back even further. Let us know your thoughts on this conversation. If you want to learn more about how you show up as a leader, take our free leadership quiz at www.wilempowered.com #neuroscience #brainandgender #Genderandourbrains #wilempowered #womenleaders #ginarippon
As I gaze out my window, captivated by the raindrops, the thought struck me – what makes the sound of rain so incredibly calming? Thus, the inspiration for episode 157 was born. In today's installment, I delve into the effects that environmental sounds can exert on our stress management, sleep patterns, hormonal balance, and neurobiology. It's my belief that these impacts are often subtle, operating on a subconscious level, unbeknownst to many. The discussion spans the soothing tones of rain, the calming cadence of ocean waves, the melodic symphony of birds, and the bustling sounds of the city. I've included some sound clips, practical tips, and insights on how we can leverage this knowledge to enhance our well-being. Tune in for details!Want to buy me a coffee to say thanks for the episode? You can do so via Venmo or Patreon below.Venmo ID: Steph-CalPatreon: https://www.patreon.com/join/DrSCaligiurihttps://www.buymeacoffee.com/drscaligiuriFollow me on social media to see the papers I cite in this week's episode:IG: Dr.SCaligiuriFB: ThePeoplesScientistTwitter: DrSCaligiuriLinkedin: Stephanie CaligiuriTikTok: Dr.SCaligiuri Hosted on Acast. See acast.com/privacy for more information.
In neurodegenerative conditions such as Parkinson's disease (PD), patients often do not receive a diagnosis until the hallmark motor symptoms begin to manifest. This can be a decade or more after substantial changes start occurring in the brain. A major goal of the PD research field has been to develop methods for earlier detection and intervention. Over the years, there have been substantial advances in neuroimaging techniques and biological biomarkers that have allowed us to more accurately identify patients with Parkinson's disease, including the recent development of the alpha-synuclein seed amplification assay. In this episode, Dr. John Seibyl discusses his early work on neuroimaging in Parkinson's disease through to the groundbreaking, large-scale clinical trials he is involved with for assessing the impacts of neuroprotective drugs for Parkinson's disease as well as Alzheimer's disease. He also shares his perspectives as a researcher and a patient with Parkinson's disease. John is Chairman of the Board, Co-Founder, and Senior Scientist of the Institute for Neurodegenerative Disorders in New Haven, Connecticut. He is also a board-certified physician in both Psychiatry and Nuclear Medicine, and he is an Adjunct faculty member in Neurology at Yale University School of Medicine.This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.
What is consciousness? Neil deGrasse Tyson and Chuck Nice learn about the study of consciousness and how psychedelics could uncover the inner mechanisms of the brain with anesthesiologist and founder of the Michigan Psychedelic Center, George Mashour. NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/exploring-consciousness-with-george-mashour/Thanks to our Patrons Andrew O., Johnathan Kuhl, Nathan champlin, Matthew Smith-Burlage, Kareem Austin, Charles Blaksmith, and İtKopuk Cansel Işıksel for supporting us this week.
What if a brain scan was a part of our regular checkup? What if we could detect and prevent diseases like dementia far in advance, with non-invasive tech? Something as simple as just putting on a bicycle helmet? Could we accelerate treatment discovery? Improve patient outcomes? And transform neuromedicine? Joining us today is the CEO of Kernel, a company based here in Los Angeles that is up to out-of-this world stuff. I was lucky enough to visit their offices, and their tech is truly game-changing. I've even tried it on! Ryan Field is an inventor with more than 20 granted US patents, and Kernel has received over $150 million in funding and counting. Buckle up for an awesome episode. ➡️ https://www.kernel.com/ ➡️ https://rosspalmer.com/ryan-field ➡️ Follow me on Instagram: @therosspalmer ➡️ Subscribe on YouTube: @therosspalmer
------------------Support the channel------------ Patreon: https://www.patreon.com/thedissenter PayPal: paypal.me/thedissenter PayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9l PayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpz PayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9m PayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao ------------------Follow me on--------------------- Twitter: https://twitter.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. Uta Frith is Emeritus Professor of Cognitive Development at UCL Institute of Cognitive Neuroscience since 2006. She has been a Visiting Professor at the University of Aarhus at the Interacting Minds Centre from 2007 to 2015. She has been a Fellow at the Institute for Advanced Studies at the Central European University in Budapest (February - June 2014). Dr. Chris Frith is Emeritus Professor of Neuropsychology at the Wellcome Trust Centre for Neuroimaging at University College London, Visiting Professor at the Interacting Minds Centre at Aarhus University, Research Fellow at the Institute of Philosophy, and Quondam Fellow of All Souls College, Oxford. They are authors of “What Makes Us Social?”. In this episode, we focus on “What Makes Us Social?”. We start by discussing what social cognition is, and then go through topics like learning and imitation; emotions, our need to affiliate, and joint action; predicting other people's behavior; group identity; reputation; trust; mentalizing; how high-level cognitive processes interact with low-level cognitive processes; consciousness; collective problem-solving; and teaching, cumulative culture, and the role of culture in human cognition. Finally, we discuss how we can foster cooperation. -- A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, HANS FREDRIK SUNDE, BERNARDO SEIXAS, OLAF ALEX, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, JOHN CONNORS, FILIP FORS CONNOLLY, DAN DEMETRIOU, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, ADANER USMANI, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, EDWARD HALL, HEDIN BRØNNER, DOUGLAS FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, DANIEL FRIEDMAN, WILLIAM BUCKNER, PAUL-GEORGE ARNAUD, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ANTON ERIKSSON, CHARLES MOREY, ALEX CHAU, AMAURI MARTÍNEZ, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, IGOR N, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, BENJAMIN GELBART, JESSICA NOWICKI, LINDA BRANDIN, NIKLAS CARLSSON, ISMAËL BENSLIMANE, GEORGE CHORIATIS, VALENTIN STEINMANN, PER KRAULIS, KATE VON GOELER, ALEXANDER HUBBARD, LIAM DUNAWAY, BR, MASOUD ALIMOHAMMADI, JONAS HERTNER, URSULA GOODENOUGH, GREGORY HASTINGS, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, ERIK ENGMAN, AND LUCY! A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, AL NICK ORTIZ, AND NICK GOLDEN! AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, BOGDAN KANIVETS, AND ROSEY!
Dr. Jeff Ratliff continues his discussion with Dr. Michael Fox and Jacob Stubbs about their study on brain network associations in substance use disorders.
Dr. Jeff Ratliff talks with Dr. Michael Fox and Jacob Stubbs about their study on brain network associations in substance use disorders. Read the related article in Nature. Disclosures can be found at Neurology.org.
Dr. Jeff Ratliff talks with Dr. Michael Fox and Jacob Stubbs about their study on brain network associations in substance use disorders.
Dr. Francis Deng summarizes major highlights of current research and future trends from the September 2023 Neuroradiology Centennial content. Functional MRI in Neuro-Oncology: State of the Art and Future Directions. Pasquini et al. Radiology 2023; 308(3):e222028. Neuroimaging in Dementia: More than Typical Alzheimer Disease. Haller et al. Radiology 2023; 308(3):e230173. MRI of the Brain: What Is Driving Innovation in 2023? Hess. Radiology 2023; 308(3):e231657. Challenges of Preparing for Diagnostic Radiology Call. Isikbay et al. Radiology 2023; 308(3):e230421. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy. Branzoli et al. Radiology 2023; 308(3):e223255. Correlating Quantitative MRI-based Apparent Diffusion Coefficient Metrics with 24-month Neurodevelopmental Outcomes in Neonates from the HEAL Trial. Calabrese et al. Radiology 2023; 308(3):e223262.
(2:46) - Using AI To Optimize For Rapid Neural ImagingThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn more about how AI is already helping doctors better detect diseases like cancer!
Dumbest Thing of the Week: Sock Potatoes; News Items: Roman Concrete, Neuroimaging and Mental Health, Using Tumor Cells to Kill Tumors, Planet Spirals Into Star; Who's That Noisy; Your Questions and E-mails: Damascus Steel; Science or Fiction